| pubmed-article:7513121 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C1858460 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0008625 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:7513121 | lifeskim:mentions | umls-concept:C0373538 | lld:lifeskim |
| pubmed-article:7513121 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7513121 | pubmed:dateCreated | 1994-5-26 | lld:pubmed |
| pubmed-article:7513121 | pubmed:abstractText | Our purpose was to determine the detection and false-positive rates for maternal serum alpha-fetoprotein measurement to screen for fetal Down syndrome and other chromosomal abnormalities in women > or = 35 years old. | lld:pubmed |
| pubmed-article:7513121 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7513121 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7513121 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7513121 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7513121 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7513121 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7513121 | pubmed:issn | 0002-9378 | lld:pubmed |
| pubmed-article:7513121 | pubmed:author | pubmed-author:HaddowJ EJE | lld:pubmed |
| pubmed-article:7513121 | pubmed:author | pubmed-author:GoodmanD BDB | lld:pubmed |
| pubmed-article:7513121 | pubmed:author | pubmed-author:MennutiM TMT | lld:pubmed |
| pubmed-article:7513121 | pubmed:author | pubmed-author:PalomakiG EGE | lld:pubmed |
| pubmed-article:7513121 | pubmed:author | pubmed-author:ToppEE | lld:pubmed |
| pubmed-article:7513121 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7513121 | pubmed:volume | 170 | lld:pubmed |
| pubmed-article:7513121 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7513121 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7513121 | pubmed:pagination | 1073-8; discussion 1078-80 | lld:pubmed |
| pubmed-article:7513121 | pubmed:dateRevised | 2004-11-18 | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:meshHeading | pubmed-meshheading:7513121-... | lld:pubmed |
| pubmed-article:7513121 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7513121 | pubmed:articleTitle | Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older. | lld:pubmed |
| pubmed-article:7513121 | pubmed:affiliation | Univeristy of Pennsylvania Medical Center, Philadelphia 19104. | lld:pubmed |
| pubmed-article:7513121 | pubmed:publicationType | Journal Article | lld:pubmed |
